on outcome following treatment of IIAs is needed to allow adequate understanding of the risks and benefits of intervention as well as to help identify risk factors predictive of poor outcome.
This study comprises a review of our experience with 125 patients harboring 160 IIAs treated either surgically or endovascularly. All patients were evaluated independently for outcome using the mRS and the MMSE. Statistical evaluation was performed to identify predictors of treatment outcome from retrospectively collected data on demographic and clinical characteristics of patients and radiographic features of the aneurysms.
CLINICAL MATERIAL AND METHODS

Patient Selection
Data in all patients who underwent surgical or endovascular treatment of an IIA at our institution between January 1990 and December 1999 were reviewed retrospectively. An IIA was defined as an UIA that was incidentally found during neuroimaging for symptoms unrelated to the UIA (Group 1). Patients with a UIA detected at the time as an SAH from a coexisting aneurysm were also included in the study (Group 2). The ruptured aneurysms in all these patients, however, had to have been treated surgically/endovascularly at a previous date and all these patients had to be able to care for themselves (mRS score Յ 2). Patients with symptomatic UIAs (cranial nerve palsy or symptoms due to mass effect), traumatic, mycotic, and fusiform aneurysms were not included in this study.
Data Collection
Patient Characteristics. All pertinent characteristics were recorded and included age, sex, smoking history, illicit drug or alcohol use, history of SAH from a different aneurysm, family history of aneurysms, known adult polycystic kidney disease, hypertension, and ischemic heart disease; other coexisting medical illnesses such as atrial fibrillation, valvular heart disease, carotid artery disease, peripheral-vascular disease, chronic obstructive pulmonary disease, diabetes, renal insufficiency, thyroid dysfunction, and recent history of systemic malignancy. Details of the procedure performed and the results demonstrated on the postoperative angiogram (obtained in all patients) were also noted.
Aneurysm Characteristics. The presence of IIAs was confirmed in all cases by conventional four-vessel angiography. The angiograms were interpreted by neuroradiologists and reviewed independently by the primary neurosurgeon. Findings on angiography, including aneurysm size, site and number of IIAs (single/multiple) were noted. Aneurysm size (maximum fundus and neck diameter) was determined after correction for magnification. In the case of multiple aneurysms, the maximum diameter of the largest aneurysm was noted. Specific aneurysm locations were noted in all patients.
Outcome Assessment. Outcomes were assessed at 30 days (early) and 6 months postoperatively (late). Followup information was obtained by reviewing the patient's medical records, telephone survey, and clinic visit notes. All patients with poor outcomes were evaluated in the clinic. Postprocedural morbidity was defined as a new neurological deficit associated with a score of 3 or more on the mRS, 37 or a score less than 24 on the MMSE. 8 Treatment-related mortality was defined as death due to any cause occurring within 1 month of the procedure.
Statistical Analysis
Univariate logistic regression analysis was used to examine the effect of the 21 variables collected (demographic, clinical, and radiographic) on postprocedural morbidity. A probability value of less than 0.1 was used as an entry criterion into the multivariate model. Multivariate logistic regression analysis was used to identify predictors of postprocedural morbidity. A probability value of less than 0.05 was considered significant. StatView (Version 5.0; SAS Institute Inc., Cary, NC) statistical software was used for the analyses.
RESULTS
General Features
A total of 125 patients underwent surgical or endovascular treatment of 160 IIAs. The mean age was 52.6 Ϯ 12.3 years (range 28-83 years) and 95 patients (76%) were women. The majority of aneurysms in this series were in Group 1 (Fig. 1) .
Treatment of IIAs
One hundred fifty-two IIAs were treated surgically. The goal of surgery was aneurysm obliteration with preservation of the parent vessel, which was achieved in 140 aneurysms; the remaining were not amenable to clipping because of broad based necks (Ͼ 4 mm), partially thrombosed/calcified necks, and proximate perforating vessels and were wrapped (10 cases) or trapped after by-pass V. Janardhan, et al. surgery (two cases). Eight IIAs were treated endovascularly. Embolization in which Guglielmi detachable coils were placed performed in six intracavernous aneurysms and in one BA bifurcation aneurysm. One giant intracavernous aneurysm was treated with balloon occlusion of the parent vessel. Postoperative angiograms were obtained in all patients. Except the 10 aneurysms that were wrapped, complete aneurysm obliteration was noted following treatment in the remaining aneurysms. All patients in whom aneurysms were wrapped underwent follow-up examination through June 2000. Median follow-up time for these patients was 5.6 years (range 0.5-8.8 years); no aneurysm that underwent wrapping ruptured during the follow-up period.
The treatment of IIAs was not associated with any mortality, and 117 patients (93.6%) patients experienced good long-term (6-month) outcome. A review of all patients in whom transient/persistent neurological deficits developed following treatment of IIAs and the possible risk factors associated with poor outcome are shown in Table 1 . Because of the small number of adverse events at 6 months and the need to identify risk factors for all postprocedural neurological deficits (transient and persistent), postprocedural morbidity at 30 days was used as the dependent variable in the logistic regression analysis.
Risk Factors for Postprocedural Morbidity
Intracranial aneurysms were graded based on size 27 and classified as small/medium (Ͻ 13 mm) in 103 (82.4%), large (13-24 mm) in 18 (14.4%), and giant (Ͼ 24 mm) in four patients (3.2%). The mean aneurysm size was 8.9 Ϯ 5.3 mm (range 2-30 mm). For further analysis, large and giant aneurysms (Ͼ 13 mm) were grouped together (22 lesions). The relationship between aneurysm size and postprocedural morbidity is shown in Table 2 . The specific location of the IIAs is shown in * AComA = anterior communicating artery; BG = basal ganglia; EC = extracranial; ICA = internal carotid artery; MCA = middle cerebral artery; MS = mental status; PComA = posterior communicating artery; SCA = superior cerebellar artery; temp = temporary.
revealed that the specific location of the lesion was not significantly predictive of poor outcome (Table 3) . Cases were also classified based on whether anterior (113 patients) or posterior circulation aneurysms (12 cases) were treated. For the analysis, patients with multiple IIAs who underwent definitive treatment for both anterior and posterior circulation aneurysms were assigned to the posterior circulation group (three cases). The relationship between aneurysm location and postprocedural morbidity is shown in Table 2 . Twenty-five patients (20%) harbored multiple IIAs, and the mean number of IIAs in these patients was 2.4 Ϯ 0.7 (range 2-5). Univariate analysis revealed that the number of IIAs treated was not significantly predictive of poor outcome (Table 2) .
Statistical analysis was performed to identify predictors of treatment outcome. Fifteen patients (12%) were 70 years of age or older. Demographic and clinical characteristics were not predictive of postprocedural morbidity (Table 4). Multivariate logistic regression analysis indicated that treatment of aneurysms 13 mm or larger and posterior circulation aneurysms were independent determinants of postprocedural morbidity ( Table 5 ). Aneurysms that were less than 13 mm in largest diameter tended to be associated with more favorable outcomes compared with large aneurysms (Ն 13 mm) (Table 5) , and anterior circulation aneurysms tended to be associated with better outcomes compared with posterior circulation aneurysms ( Table 5) .
DISCUSSION
Overview and Salient Features
Greater availability of noninvasive neuroimaging 1, 4, 34, 38 has led to an increase in the detection of IIAs. 21 Rupture of IIAs and the subsequent complications of SAH can be prevented by early treatment. The treatment of IIAs, however, is not without risk. Although morbidity and mortality associated with surgical management of unruptured aneurysms have been documented in several studies, the range of reported values is wide (0-16.7% for morbidity and 0-7.7% for mortality), 13, 20, 28 and the risk factors associated with poor outcome have not been clearly defined. 35 In the present series we found that IIAs can be safely and effectively treated without mortality and low morbidity.
Moreover, a combination of neuroimaging variablesnamely, aneurysm size and location-can be helpful in identifying those patients at increased risk for poor outcome.
Natural History of IIAs
Treatment of IIAs may be recommended after weighing the relative risks of observation compared with the morbidity associated with intervention. Jane, et al., 14 and Winn, et al., 42 have shown that the annual risk of rupture of IIAs is around 1%. The ISUIA has shown that the annual risk of rupture is approximately 1% only for aneurysms greater than or equal to 10 mm and that aneurysms less than 10 mm have a negligible risk of rupture (0.05%/year in Group 1 and 0.5%/year in Group 2 aneurysms). 13 In contrast, Rinkel, et al., 31 in their systematic review of all natural history studies conducted between 1955 and 1996, found that the overall annual rupture rate for UIAs is 1.9% (4%/year for aneurysms Ն 10 mm and 0.7%/year for aneurysms Ͻ 10 mm). 30 The discrepancy in the aneurysmal rupture rates between the systematic review and the ISUIA has been partly attributed to the shorter followup period of 8.3 years in the ISUIA compared with the 13.9-year period of Juvela, et al. 15 Additional data from the prospective arm of the ISUIA should help resolve the above issue.
Juvela, et al., 16 have recently reported data on the longterm natural history of UIAs. In a series of 142 patients with 181 UIAs (median follow-up time) 19.7 years, range 0.8-38.9 years, they estimated the overall annual risk of rupture to be 1.3% (2.8%/year for aneurysms Ն 10 mm and 1.1-2.3%/year for aneurysms Ͻ 10 mm) and a cumulative risk of rupture of 10.5% at 10 years. In their series, because 131 of 142 patients harbored Group 2 aneurysms, data on the annual risk of rupture of Group 1 aneurysms is limited. Tsutsumi, et al., 36 in a community-based followup study, have attempted to address the issue of the risk of rupture in Group 1 aneurysms. In their series of 62 patients with 83 IIAs (mean follow-up time of 4.3 years, range 0.5-17 years), they estimated the cumulative risk of rupture of IIAs at 10 years to be 22.1% (55.9%/10 years for aneurysms Ն 10 mm and 22.1%/10 years for aneurysms Ͻ 10 mm). Evaluation of results obtained in these V. Janardhan, et al. It has been suggested that aneurysm size is an important determinant in risk for rupture. 13, 18 In previous studies by Wiebers, et al., 40, 41 findings were similar to those in the ISUIA, 13 suggesting that the critical size limit for subsequent rupture is 10 mm. Numerous authors have shown, however, that even small UIAs (Ͻ 5 mm) are not innocuous and can also rupture. 33, 44, 45 Juvela, et al., 16 have recently reported that 23 of 33 aneurysms that ruptured were initially 6 mm or less in size. Juvela, et al., 15, 16 have shown that aneurysm size was in fact an important risk factor for rupture, as were age and active smoking status, but could not identify any critical size limit for subsequent rupture and have suggested that all patients with UIAs be offered treatment irrespective of aneurysm size (if technically possible and if age and clinical condition permit).
Treatment-Related Risks
Treatment of IIAs is not without risk. To study the risks of intervention, King, et al., 19 performed a metaanalysis of all outcome studies on IIAs conducted between 1966 and 1992 and showed that the morbidity and mortality rates associated with treatment were 4.1 and 1%, respectively. In another metaanalysis, the morbidity and mortality rates associated with treating UIAs were 10.9 and 2.6%, respectively. 28 The higher rates of morbidity and mortality in this metaanlaysis have been attributed to the relatively higher percentage of patients with giant and posterior circulation aneurysms as well as the inclusion of patients with symptomatic aneurysms. The recent results of the ISUIA suggest that the postprocedural morbidity and mortality rates could be as high as 11.9 to 12.1 and 1 to 3.8%, respectively. 13 These authors have attributed the higher risks of intervention to the additional inclusion of impaired mental status in their overall assessment of functional outcome. The results in the present series, in which patients were evaluated by an independent observer other than the primary neurosurgeon and standardized neurological outcome scales were applied, indicate a postprocedural morbidity rate at 6 months of 6.4% (eight cases) and no mortality. This is less than that reported in the ISUIA and compares favorably with the outcomes in previous studies. 10, 20, 22, 25, 26, 31, 32, 43 In addition, half the patients with postprocedural neurological deficits at 30 days subsequently recovered to their functional baseline. Cognitive impairment as an independent factor was not significantly associated with postprocedural morbidity at 6 months.
Risk factors for Postprocedural Morbidity
Our findings suggests that treatment of large (Ն 13 mm) and posterior circulation aneurysms were independently associated with poor outcome. The authors of several studies have shown that aneurysm size is an important determinant of surgery-related outcome.
13,22,25,28 Khanna, et al., 19 have shown that a 25-mm aneurysm has a fourfold higher risk of poor outcome after surgery compared with a 5-mm aneurysm. The increased risk of postprocedural neurological deficits in patients with large aneurysms is multifactorial and related to the technical intraoperative difficulties including limited manipulation space, the need for temporary clipping, and the risks of prolonged occlusion, proximate perforating vessels, broad/atherosclerotic/calcified necks, and an increased risk of intraluminal thrombosis. 9, 24 The location of the aneurysm is also an important predictor of poor outcome as shown in the present study. Posterior circulation aneurysms, in particular, tend to be associated with worse outcomes. 19, 25, 28 This has been attributed to limited surgical accessibility, close apposition to cranial nerves, and multiple perforators.
2, 29 Rice, et al., 29 have reported a combined 4.2% morbidity and mortality rate associated with the treatment of nongiant posterior circulation aneurysms. Raaymakers, et al., 27 have shown
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Incidental intracranial aneurysms 5 that the morbidity and mortality rates associated with treating nongiant anterior circulation aneurysms are 1.9 and 0.8%, respectively, and for giant posterior circulation aneurysms are 37.9 and 9.6%, respectively. The results in the present series support the previous findings that posterior circulation aneurysms have poorer surgery-related outcomes. 2, 3, 19, 28 Because of the small sample size, however, adequate data could not be derived for specific aneurysm locations.
It has been suggested that surgery-related outcome is associated with the number of IIAs harbored by the patient. 25 Excessive brain manipulation was cited as the cause. 25 No such association could be identified in the current series of 25 patients with multiple IIAs.
Age of the patient has been suggested as an independent predictor of poor outcome. 13, 19 Kashiwagi, et al., 17 have reported good outcomes in elderly patients (Ն 70 years of age) who underwent elective neck clipping and suggest that surgery for patients with UIAs should not be withheld on the basis of age alone. Juvela, et al., 16 have shown that age is inversely related to aneurysm rupture and that young and middle-aged adults (Ͻ 50 years) with UIAs should be treated surgically, irrespective of aneurysm size. The median age of patients in their study was 41.9 (range 14.6-60.7 years) and even in patients greater than age 50 years they found that the 10-year cumulative risk of rupture was 15%, thus suggesting the potential benefit of surgical treatment in elderly patients-if technically possible and if concurrent medical illnesses do not increase surgical risk. 15, 16 Although age and coexisting medical illnesses were not directly related to poor outcome in the present series, the life expectancy and the severity of comorbid illnesses should play a part in the decision-making process, and the suitability of treating IIAs in elderly patients with comorbidities should be considered on an individual basis. 5 Factors other than aneurysm size and location may influence adverse outcome, demonstrated by the fact that 11 (10.6%) of 103 patients with aneurysms less than 13 mm in size and 13 (11.5%) of 113 patients with anterior circulation aneurysms also suffered postprocedural neurological deficits. In the present series, 12 (70.6%) and four (23.5%) of 17 patients with postprocedural neurological deficits harbored aneurysms with broad (Ͼ 4 mm) and calcified necks, respectively. Ohno, et al., 24 have documented ischemic complications associated with treating calcified-neck aneurysms and observed that these aneurysms are also more likely to be broad necked. These ischemic complications have been attributed to kinking/ stenosis of the parent artery by clipping, possible injury V. Janardhan, et al. 6 Neurosurg. Focus / Volume 13 / September, 2002 † Negative value suggests the inverse relationship between treatment of anterior circulation aneurysms less than 13 mm and postprocedural morbidity.
‡ Statistically significant.
of the parent artery during dissection and migration of thrombi from the aneurysm. Computerized tomography angiography seems to be increasingly used for better demonstration of these broad-necked and calcified aneurysms. 34 Broad-necked aneurysms are also technically more difficult to treat surgically or endovascularly. 23, 24 Dual-modality treatment in which surgical and endovascular methods are used has been proposed. 6 Further prospective studies are needed to validate the predictive significance of these neuroimaging variables.
CONCLUSIONS
Intracranial aneurysms can be safely and effectively treated with fewer risks than previously reported. 13 A combination of neuroimaging variables-namely, aneurysm size and location-may be helpful in identifying patients at risk for postprocedural morbidity. A decision to treat an IIA ultimately depends on weighing the relative risks of subsequent aneurysm rupture and the risks of intervention. Although the risks of intervention have been documented, the natural history of IIAs remains unclear, and data from the prospective arm of the ongoing ISUIA should help address this issue.
